Substance Use Disorders (SUD)Ibogaine

The iboga alkaloids

This academic book chapter (2017) offers the latest insight into the iboga alkaloids and related compounds (e.g. 18-MC) in order to update knowledge on the most recent advancements in the field.

Authors

  • Lavaud, C.
  • Massiot, G.

Published

Progress in the Chemistry of Organic Natural Products
meta Study

Abstract

Iboga alkaloids are a particular class of indolomonoterpenes most often characterized by an isoquinuclidine nucleus. Their first occurrence was detected in the roots of Tabernanthe iboga, a sacred plant to the people of Gabon, which made it cult object. Ibogaine is the main representative of this class of alkaloids and its psychoactive properties are well documented. It has been proposed as a drug cessation treatment and has a wide range of activities in targeting opioids, cocaine, and alcohol. The purpose of this chapter is to provide a background on this molecule and related compounds and to update knowledge on the most recent advances made. Difficulties linked to the status of ibogaine as a drug in several countries have hampered its development, but 18-methoxycoronaridine is currently under evaluation for the same purposes and for the treatment of leishmaniasis. The chapter is divided into six parts: an introduction aiming at defining what is called an iboga alkaloid, and this is followed by current knowledge on their biosynthesis, which unfortunately remains a “black box” as far as the key construction step is concerned. Many of these alkaloids are still being discovered and the third and fourth parts of the chapter discuss the analytical tools in use for this purpose and give lists of new monomeric and dimeric alkaloids belonging to this class. When necessary, the structures are discussed especially with regard to absolute configuration determinations, which remain a point of weakness in their assignments. Part V gives an account of progress made in the synthesis, partial and total, which the authors believe is key to providing solid solutions to the industrial development of the most promising molecules. The last part of the chapter is devoted to the biological properties of iboga alkaloids, with particular emphasis on ibogaine and 18-methoxycoronaridine.

Available with Blossom Pro

Research Summary of 'The iboga alkaloids'

Introduction

The paper defines "iboga alkaloids" at four overlapping levels: alkaloids isolated from Tabernanthe iboga; psychoactive alkaloids used in Central African ceremonial contexts; a chemical definition based on an indole nucleus fused to an isoquinuclidine system; and a biogenetic definition tied to specific rearrangements of secologanoside-derived carbons. Lotsof and colleagues adopt a biogenetic nomenclature for the review and restrict coverage to alkaloids built on the ibogan, isoplumeran and isoeburnan skeletons. The authors note that only a small subset of Apocynaceae genera produce these alkaloids and that, among roughly 100 known iboga-type compounds, catharanthine and ibogaine have driven the most chemical and biological interest, the latter for its putative anti‑addiction properties. This chapter aims to update chemical, biosynthetic, structural, synthetic and biological knowledge of iboga alkaloids from literature published roughly between 2000 and 2016. In doing so, the authors emphasise unresolved questions in biosynthesis, challenges in absolute configuration determination and the continued discovery of new monomeric and dimeric iboga derivatives, while signalling the medicinal interest in ibogaine and synthetic analogues such as 18‑OMe‑coronaridine (18‑MC).

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

References (5)

Papers cited by this study that are also in Blossom

Treatment of acute opioid withdrawal with ibogaine

Alper, K. R., Lotsof, H. S., Frenken, G. M. N. et al. · The American Journal on Addictions (2010)

The ibogaine medical subculture

Alper, K. R., Lotsof, H. S., Kaplan, C. D. · Journal of Ethnopharmacology (2007)

Ibogaine in the treatment of substance dependence

Brown, T. K. · Current Drug Abuse Reviews (2013)

Psychedelics and the human receptorome

Ray, T. S. · PLOS ONE (2010)

265 cited
Effect of Iboga Alkaloids on µ-Opioid Receptor-Coupled G Protein Activation

Antonio, T., Childers, S. R., Rothman, R. B. et al. · PLOS ONE (2013)

Cited By (4)

Papers in Blossom that reference this study

A systematic literature review of clinical trials and therapeutic applications of ibogaine

Köck, P., Frölich, K., Walter, M. et al. · Journal of Substance Abuse Treatment (2022)

46 cited

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.